Kymera patent
TīmeklisUS9932350B2 US15/515,377 US201515515377A US9932350B2 US 9932350 B2 US9932350 B2 US 9932350B2 US 201515515377 A US201515515377 A US 201515515377A US 9932350 B2 US9932350 B2 US 9932 TīmeklisKymera Therapeutics, Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no … Discuss; 102000004169 proteins and genes Human genes 0.000 title claims abstract …
Kymera patent
Did you know?
Tīmeklis2024. gada 1. febr. · The patent applications also claimed that these PROTACs can degrade different proteins and provide a good strategy for treating diseases such as cancer. 5. The advantages of PROTACs. Traditional small molecule inhibitors have many limitations. The selection pressure of small molecule kinase inhibitors often … Tīmeklis2024. gada 16. dec. · Kymera’s goal is to be a fully integrated biopharmaceutical company at the forefront of this new class of protein degrader medicines, with a …
Tīmeklis1 patent awarded (WO Patent WO/2009/043,829, Proteome-Wide Quantification of Small Molecule Binding To Cellular Target Proteins) … Tīmeklis2013. gada 23. apr. · Hughes Christensen Kymera™ hybrid drill bit technology combines roller cones and PDC fixed cutters into a single, patented design to reduce drilling time in ...
Tīmeklis2024. gada 3. aug. · Introducing Kymera 328i. Andor Technology Ltd., an Oxford Instruments company and world leader in scientific imaging and spectroscopy solutions, today announced the launch of the Kymera 328i imaging spectrograph. This highly modular spectrograph features patented Adaptive Focus, quadruple on-axis … TīmeklisThe patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee. ... KYMERA® and Tricone drill bits are, respectively, hybrid (both rolling cutting structures and fixed ...
Tīmeklis2024. gada 6. marts · Targeted degraders first entered the patent literature in 1999, ... Kymera’s targeted protein degrader of IRAK4 demonstrates another set of near-term opportunities for the targeted …
TīmeklisUnited States Patent Application 20240010468 . Kind Code: A1 . Abstract: The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders. ... Kymera Therapeutics, Inc. (Cambridge, MA, US) International Classes: C07D471/14; … destiny fallen scorch cannonTīmeklisKymera Therapeutics Apr 2024 - Jan 2024 10 months. Cambridge, Massachusetts, United States ... Associate / Patent Agent / … chuhn ansibleTīmeklisUnited States Patent Application 20240010468 . Kind Code: A1 . Abstract: The present invention provides compounds, compositions thereof, and methods of using the … destiny farm black wax idolshttp://kimeratechnologies.com/ chuhome.ccTīmeklisAccurate, Flexible Spectroscopy in any Lab. Kymera offers high resolution, high throughput and high modularity from the UV to the NIR and SWIR, and from macro-scale to nano-scale, with fluxes down to a single photon and time-resolution down to a nanosecond. This modular, multi-modal Optical Spectrometer is rich in meaningful … chuh library loginTīmeklisRefleXion Medical is developing the first biologically guided radiation therapy system for treating solid tumors throughout the body. By uniquely leveraging Positron Emission Tomography (PET), RefleXion's patented technology uses signals that are continuously emitted from the tumor itself to guide the treatment beam. chu hopital liegeTīmeklisComputer Vision solutions for your company Discover how AI solutions can improve your products free DEMO USE CASES Kimera Technologies is a precise, easy-to … chu hopital nord grenoble